Live feed08:30:00·23dPRReleaseTarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme DiseaseTARS· Tarsus Pharmaceuticals Inc.Health CareOriginal source
